A Chinese community-based cohort including 4329 adults showed that BMI significantly modulated the APOA5 rs662799 genetic effects on dyslipidemia risk (Lin et al. 2022), in line with the BMI–APOA5 rs662799 interaction on TG (Fig. 5). The gene discussed is APOA5; the disease is metabolic syndrome.